MX359104B - Derivados de polimixina y su uso en terapia de combinacion junto con diferentes antibioticos. - Google Patents

Derivados de polimixina y su uso en terapia de combinacion junto con diferentes antibioticos.

Info

Publication number
MX359104B
MX359104B MX2016011682A MX2016011682A MX359104B MX 359104 B MX359104 B MX 359104B MX 2016011682 A MX2016011682 A MX 2016011682A MX 2016011682 A MX2016011682 A MX 2016011682A MX 359104 B MX359104 B MX 359104B
Authority
MX
Mexico
Prior art keywords
combination therapy
different antibiotics
therapy together
polymyxin derivatives
iii
Prior art date
Application number
MX2016011682A
Other languages
English (en)
Spanish (es)
Other versions
MX2016011682A (es
Inventor
Brown Pamela
Dawson Michael
Simonovic Mona
Boakes Steven
Duperchy Esther
James Stanway Steven
Wilson Antoinette
Frederick Moss Stephen
Original Assignee
New Pharma Licence Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB201404301A external-priority patent/GB201404301D0/en
Priority claimed from GB201421019A external-priority patent/GB201421019D0/en
Application filed by New Pharma Licence Holdings Ltd filed Critical New Pharma Licence Holdings Ltd
Publication of MX2016011682A publication Critical patent/MX2016011682A/es
Publication of MX359104B publication Critical patent/MX359104B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2016011682A 2014-03-11 2015-03-11 Derivados de polimixina y su uso en terapia de combinacion junto con diferentes antibioticos. MX359104B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201404301A GB201404301D0 (en) 2014-03-11 2014-03-11 Compounds and combinations
GB201421019A GB201421019D0 (en) 2014-11-26 2014-11-26 Compounds
PCT/EP2015/055046 WO2015135976A1 (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics

Publications (2)

Publication Number Publication Date
MX2016011682A MX2016011682A (es) 2017-04-27
MX359104B true MX359104B (es) 2018-09-14

Family

ID=52823596

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016011682A MX359104B (es) 2014-03-11 2015-03-11 Derivados de polimixina y su uso en terapia de combinacion junto con diferentes antibioticos.

Country Status (21)

Country Link
US (3) US20170073373A1 (enExample)
EP (1) EP3116897B1 (enExample)
JP (1) JP6785659B2 (enExample)
KR (2) KR20160135739A (enExample)
CN (1) CN106232617B (enExample)
AU (1) AU2015228898B2 (enExample)
CA (1) CA2940455C (enExample)
CY (1) CY1125175T1 (enExample)
DK (1) DK3116897T3 (enExample)
ES (1) ES2910072T3 (enExample)
HR (1) HRP20220387T1 (enExample)
IL (1) IL247243B (enExample)
LT (1) LT3116897T (enExample)
MX (1) MX359104B (enExample)
PL (1) PL3116897T3 (enExample)
PT (1) PT3116897T (enExample)
RS (1) RS63138B1 (enExample)
RU (1) RU2740190C2 (enExample)
SI (1) SI3116897T1 (enExample)
TW (1) TWI709575B (enExample)
WO (1) WO2015135976A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX355217B (es) * 2011-11-18 2018-04-10 New Pharma Licence Holdings Ltd Derivados de polimixina.
US10047126B2 (en) 2014-04-01 2018-08-14 Monash University Polymyxin derivatives as antimicrobial compounds
CN107108699A (zh) 2014-11-26 2017-08-29 新药物许可控股有限公司 化合物
EP3233889B1 (en) 2014-12-16 2022-07-06 Shanghai MicuRx Pharmaceutical Co., Ltd. Antimicrobial polymyxins for treatment of bacterial infections
CN105030744B (zh) * 2015-07-09 2019-04-19 广州英赛特生物技术有限公司 取代苯胍衍生物作为多粘菌素类抗生素增效剂的应用
JP7367950B2 (ja) * 2015-09-29 2023-10-24 モナッシュ ユニバーシティ 抗菌性ポリミキシン誘導体化合物
JP6744622B2 (ja) * 2016-06-16 2020-08-19 学校法人上智学院 ピペリジン化合物の製造方法
WO2019084628A1 (en) 2017-11-02 2019-05-09 The University Of Queensland Peptide antibiotics
DK3810633T3 (da) 2018-06-25 2024-01-15 Spero Therapeutics Inc Forbindelser
CN111690040A (zh) * 2019-03-12 2020-09-22 上海来益生物药物研究开发中心有限责任公司 多粘菌素衍生物、其制备方法和应用
WO2021150792A1 (en) 2020-01-21 2021-07-29 Micurx Pharmaceuticals, Inc. Novel compounds and composition for targeted therapy of kidney-associated cancers
TW202233649A (zh) 2020-11-06 2022-09-01 美商斯佩羅治療學股份有限公司 化合物
CN116847735B (zh) * 2021-02-02 2026-02-03 韩国生命工学研究院 含有联苯基衍生物化合物作为有效成分的抗菌佐剂及其用途
CN120574287B (zh) * 2025-06-10 2026-07-03 中国药科大学 一种抗菌肽、组合物及应用
CN120699105B (zh) * 2025-08-19 2025-11-21 中国药科大学 一种氘代抗菌肽及其组合物和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
BRPI0715095B8 (pt) * 2006-08-11 2021-05-25 Northern Antibiotics Oy derivado de polimixina da fórmula geral (i); produto de combinação; composição farmacêutica; método para se sensibilizar bactérias gram-negativas a um agente antibacteriano; método para o desenvolvimento de antibióticos; método para a redução da toxicidade de polimixinas, octapeptinas naturais e seus derivados durante a aplicação das mesmas no tratamento de infecções em um indivíduo; método para melhorar as propriedades farmacocinéticas, de polimixinas, octapeptinas naturais e seus derivados; método para a sensibilização de bactérias gram-negativas clinicamente importantes a um complemento de mecanismo de defesa presente no soro; uso de um derivado; e processo para a preparação de um derivado de polimixina da fórmula (i).
WO2010075416A1 (en) * 2008-12-23 2010-07-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
CN101851270A (zh) * 2009-04-03 2010-10-06 梁浩 一种多粘菌素衍生物及其制备方法
US8415307B1 (en) * 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2012168820A1 (en) * 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
MX355217B (es) * 2011-11-18 2018-04-10 New Pharma Licence Holdings Ltd Derivados de polimixina.
HUE059544T2 (hu) * 2013-05-22 2022-11-28 Spero Therapeutics Inc Polimixin-származékok és ezek alkalmazása kombinációs terápiában különbözõ antibiotikumokkal

Also Published As

Publication number Publication date
PL3116897T3 (pl) 2022-05-30
KR20160135739A (ko) 2016-11-28
IL247243B (en) 2020-04-30
SI3116897T1 (sl) 2022-06-30
RS63138B1 (sr) 2022-05-31
EP3116897A1 (en) 2017-01-18
JP6785659B2 (ja) 2020-11-18
ES2910072T3 (es) 2022-05-11
CA2940455A1 (en) 2015-09-17
HRP20220387T1 (hr) 2022-05-27
CN106232617A (zh) 2016-12-14
IL247243A0 (en) 2016-09-29
AU2015228898A1 (en) 2016-10-20
US20230322858A1 (en) 2023-10-12
RU2016139978A3 (enExample) 2018-10-17
JP2017510570A (ja) 2017-04-13
AU2015228898B2 (en) 2018-11-15
MX2016011682A (es) 2017-04-27
US20170073373A1 (en) 2017-03-16
PT3116897T (pt) 2022-04-07
EP3116897B1 (en) 2022-03-02
DK3116897T3 (da) 2022-03-28
TW201617362A (zh) 2016-05-16
CN106232617B (zh) 2022-06-24
US20210221848A1 (en) 2021-07-22
RU2740190C2 (ru) 2021-01-12
KR20230152779A (ko) 2023-11-03
CY1125175T1 (el) 2024-12-13
LT3116897T (lt) 2022-05-10
CA2940455C (en) 2023-03-21
TWI709575B (zh) 2020-11-11
WO2015135976A1 (en) 2015-09-17
RU2016139978A (ru) 2018-04-13

Similar Documents

Publication Publication Date Title
MX2016011682A (es) Derivados de polimixina y su uso en terapia de combinacion junto con diferentes antibioticos.
CA2909335C (en) Fenfluramine for use in the treatment of dravet syndrome
NZ713621A (en) Compounds and methods of treating infections
WO2014188178A9 (en) Polymyxin derivatives and their use in combination therapy together with different antibiotics
ZA202001513B (en) Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
AU2015352440B2 (en) Compounds
MX363678B (es) Terapia de combinación que comprende oxazolidinona-quinolonas para usarse en el tratamiento de infecciones bacterianas.
MX2017000312A (es) Derivados de isoindolina para usarse en el tratamiento de una infeccion viral.
MX2016009251A (es) Derivados de 7-oxo-1, 6-diazabiciclo [3.2.1] octano y su uso como agentes antibacterianos.
BR112017026061A2 (pt) composto, uso de um composto, e, método de tratamento de uma infecção viral
WO2018217710A8 (en) Micro-nanobubble solutions for tissue preservation and generation thereof
EA201591362A1 (ru) Соединения и способы лечения бактериальных инфекций
MA40535A (fr) Imagerie et thérapie d'une inflammation et d'une infection ciblant hsp90
SA517381678B1 (ar) مركبات داي هيدرو بيريميدين-2-أون واستخدامها الطبي
EP3285787B8 (en) Treatment of bacterial infections in aquaculture
PL3856213T3 (pl) Sposoby leczenia zakażenia z zastosowaniem bakterii
IN2013MU03216A (enExample)
SG11202102791SA (en) Indane derivatives for use in the treatment of bacterial infection
EP3193946A4 (en) Saccharide analogs and agents for the diagnosis and therapy of bacterial infections
EA201990995A1 (ru) Терапия постоперационной рвоты амисульпридом
SG10201903630UA (en) Iminosugars useful for the treatment of viral diseases
WO2016072854A3 (en) Pantothenamide analogues
HK1240940A1 (en) Polymyxin derivatives and their use in combination therapy together with different antibiotics
EP3538094A4 (en) FORMULATIONS, METHODS, KIT AND PHARMACEUTICAL FORMS FOR TREATING BACTERIAL INFECTIONS
EA201692164A1 (ru) Лекарственное средство для лечения пациентов с тиннитусом

Legal Events

Date Code Title Description
FG Grant or registration